text: Asymptomatic cryptococcal antigenemia is very common in areas with endemic HIV/AIDS, and is associated with increased mortality and incidence of cryptococcal meningitis. Screening is not recommended for HIV/AIDS patients in the United States or Europe. However, screening may be beneficial in countries with limited HAART availability, high levels of antiretroviral drug resistance, and a high burden of disease. In the absence of symptoms, positive cryptococcal antigenemia should be treated with fluconazole 400 mg orally, once daily.
option_0: Cryptococcosis screening
option_1: Coccidioidomycosis screening
option_2: Echinococcosis screening
option_3: Mycosis fungoides screening
option_4: Langerhans cell histiocytosis screening
option_5: Toxoplasmosis screening
option_6: Splenic marginal zone lymphoma screening
option_7: Lymphomatoid granulomatosis screening